These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 18345974)

  • 1. Management of epilepsy in tuberous sclerosis complex.
    Curatolo P; D'Argenzio L; Cerminara C; Bombardieri R
    Expert Rev Neurother; 2008 Mar; 8(3):457-67. PubMed ID: 18345974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberous sclerosis and epilepsy.
    Petrova LD
    Am J Electroneurodiagnostic Technol; 2011 Mar; 51(1):5-15. PubMed ID: 21516926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epileptic spasms in tuberous sclerosis complex.
    Hsieh DT; Jennesson MM; Thiele EA
    Epilepsy Res; 2013 Sep; 106(1-2):200-10. PubMed ID: 23796861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epilepsy in children with tuberous sclerosis complex: Chance of remission and response to antiepileptic drugs.
    Overwater IE; Bindels-de Heus K; Rietman AB; Ten Hoopen LW; Vergouwe Y; Moll HA; de Wit MC
    Epilepsia; 2015 Aug; 56(8):1239-45. PubMed ID: 26046563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infantile spasms in tuberous sclerosis complex: prognostic utility of EEG.
    Muzykewicz DA; Costello DJ; Halpern EF; Thiele EA
    Epilepsia; 2009 Feb; 50(2):290-6. PubMed ID: 18801034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current management for epilepsy in tuberous sclerosis complex.
    Curatolo P; Bombardieri R; Cerminara C
    Curr Opin Neurol; 2006 Apr; 19(2):119-23. PubMed ID: 16538083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyst-like tubers are associated with TSC2 and epilepsy in tuberous sclerosis complex.
    Chu-Shore CJ; Major P; Montenegro M; Thiele E
    Neurology; 2009 Mar; 72(13):1165-9. PubMed ID: 19332694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment before seizures: new indications for antiepileptic therapy in children with tuberous sclerosis complex.
    Józwiak S; Domańska-Pakieła D; Kotulska K; Kaczorowska M
    Epilepsia; 2007 Aug; 48(8):1632; author reply 1632-4. PubMed ID: 17692054
    [No Abstract]   [Full Text] [Related]  

  • 9. Tuberous sclerosis complex and epilepsy: recent developments and future challenges.
    Holmes GL; Stafstrom CE;
    Epilepsia; 2007 Apr; 48(4):617-30. PubMed ID: 17386056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberous sclerosis as an underlying basis for infantile spasm.
    Yeung RS
    Int Rev Neurobiol; 2002; 49():315-32. PubMed ID: 12040899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early control of seizures improves long-term outcome in children with tuberous sclerosis complex.
    Bombardieri R; Pinci M; Moavero R; Cerminara C; Curatolo P
    Eur J Paediatr Neurol; 2010 Mar; 14(2):146-9. PubMed ID: 19369101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease.
    Astrinidis A; Henske EP
    Oncogene; 2005 Nov; 24(50):7475-81. PubMed ID: 16288294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vigabatrin in the treatment of childhood epilepsy: a retrospective chart review of efficacy and safety profile.
    Camposano SE; Major P; Halpern E; Thiele EA
    Epilepsia; 2008 Jul; 49(7):1186-91. PubMed ID: 18479386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infantile spasm-associated microencephaly in tuberous sclerosis complex and cortical dysplasia.
    Chandra PS; Salamon N; Nguyen ST; Chang JW; Huynh MN; Cepeda C; Leite JP; Neder L; Koh S; Vinters HV; Mathern GW
    Neurology; 2007 Feb; 68(6):438-45. PubMed ID: 17283320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of 65 tuberous sclerosis complex (TSC) patients by TSC2 DGGE, TSC1/TSC2 MLPA, and TSC1 long-range PCR sequencing, and report of 28 novel mutations.
    Rendtorff ND; Bjerregaard B; Frödin M; Kjaergaard S; Hove H; Skovby F; Brøndum-Nielsen K; Schwartz M;
    Hum Mutat; 2005 Oct; 26(4):374-83. PubMed ID: 16114042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense suppression of TSC1 gene product, hamartin, enhances neurite outgrowth in NGF-treated PC12h cells.
    Floricel F; Higaki K; Maki H; Nanba E; Ninomiya H; Ohno K
    Brain Dev; 2007 Sep; 29(8):502-9. PubMed ID: 17376623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epilepsy in Tuberous Sclerosis: Phenotypes, Mechanisms, and Treatments.
    Saxena A; Sampson JR
    Semin Neurol; 2015 Jun; 35(3):269-76. PubMed ID: 26060906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapamycin as a therapy of choice after renal transplantation in a patient with tuberous sclerosis complex.
    Tarasewicz A; Debska-Slizień A; Konopa J; Zdrojewski Z; Rutkowski B
    Transplant Proc; 2009 Nov; 41(9):3677-82. PubMed ID: 19917366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vigabatrin for Epileptic Spasms and Tonic Seizures in Tuberous Sclerosis Complex.
    van der Poest Clement EA; Sahin M; Peters JM
    J Child Neurol; 2018 Jul; 33(8):519-524. PubMed ID: 29687739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vigabatrin and mental retardation in tuberous sclerosis: infantile spasms versus focal seizures.
    Yum MS; Lee EH; Ko TS
    J Child Neurol; 2013 Mar; 28(3):308-13. PubMed ID: 22752486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.